Free · no card
Get what investors say about AMGN next
2 new calls on AMGN this week are not on this page yet. Follow AMGN free and new calls come to you in The Brief, our morning email, the day after we record them. This page shows them a week later.
or continue with Google ·
Who said what, and what AMGN did next
Every dot is a day someone on the record made a call. Hover one to see who. We are not scoring them — the point is that you can see it and judge for yourself.
Who’s talking about AMGN
| Date | Voice | Stance | Venue | Thesis |
|---|---|---|---|---|
| 2026-10-26 | Unknown | Bullish | CNBC (uncut) | Large-cap pharma broadly working; Amgen specifically has an imminent earnings catalyst plus a new drug combo… |
| 2026-09-18 | Mark SkousenEditor, Forecasts & Strategies; professor, Chapman University | Bullish | Wealthion | Amgen is developing new drug technologies that will benefit people over time and has AI-adjacent exposure… |
| 2026-08-04 | Rob Sechan (NewEdge Wealth)Co-founder & CEO, NewEdge Wealth | Bullish | CNBC Halftime Final Trades | Amgen is entering the GLP-1 space as a potential upside catalyst, has one of the best pipelines in biotech… |
| 2023-02-25 | Tobias CarlisleFounder & CIO, Acquirers Funds | Bullish | We Study Billionaires | Amgen is quantitatively cheap at a 7%+ FCF yield to enterprise value — well above the 4.5% 10-year treasury —… |
| 2023-02-15 | Unknown | Bullish | CNBC Halftime Final Trades | Amgen is a biotech leader in arthritis treatment while also building an obesity franchise, positioning it at… |
Next report: 3 Nov 2026 after the close
Notable options days
Sessions in the last 120 where AMGN’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 10 of 120 sessions qualified.
| Date | Close | RVOL | Δ$ flow ($M) | Call % | LEAPS % | +20 sess. |
|---|---|---|---|---|---|---|
| 2026-10-30 | ||||||
| 2026-10-15 | ||||||
| 2026-09-17 | ||||||
| 2026-09-10 | ||||||
| 2026-09-08 | ||||||
| 2026-08-20 | ||||||
| 2026-08-19 | ||||||
| 2026-08-05 | ||||||
| 2026-07-17 | ||||||
| 2026-05-14 |
AMGN on the Wheel
AMGN did not pass our 1-month put test (V3); the Wheel shows its puts without calling one best.
The Wheel lists cash-secured puts on stocks after a 3% drop, with live quotes, the chance of assignment and each stock’s own history. Free to use; a free account lets you follow stocks, add your own and ask questions.
Decision support, not advice · questions put sellers ask us
Idea Scout
Following AMGN? Every Sunday we read the tape so you don't have to — who's recommending what, where they agree, and who just changed their mind. One free email a week.
Free · double opt-in · unsubscribe in one click